The ENABLE Adherence Network & Innovation Hub is a global consortium dedicated to advancing medication adherence research, innovation, and implementation. Building on the achievements of the ENABLE COST Action (CA19132), the network brings together 22 member organisations worldwide committed to improving how medication adherence technologies and interventions are developed, evaluated, and integrated into healthcare systems.
ENABLE promotes collaboration across disciplines and countries to advance three key areas: training, research, and innovation. The consortium provides interdisciplinary training for professionals and researchers, conducts and supports multi-country research projects, and generates evidence to inform the adoption of effective adherence-enhancing solutions.
ENABLE also maintains and further develops the MATech Repository, an open-access database of medication adherence technologies that supports researchers, healthcare professionals, developers, policymakers, regulators, insurers, and patients. Through its international network and collaborative activities, ENABLE contributes to the development and implementation of patient-centred approaches that improve medication adherence and health outcomes.